A 2-year-old boy developed pallor, sweating, agitation, fainting and perioral cyanosis during treatment with nonacog-α [Recombinant FIX, BeneFIX, rFIX] and agitation, cough, facial hyperaemia and cyanosis following challenge test and desensitization protocol with factor IX. …